Drug recall · May 15, 2019
Mycophenolate Mofetil for Injection recall
Why: Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044
- Lots / codes
AD812, exp 9/2020
- Quantity
- 4506 packs
- Company
- Par Pharmaceutical, Inc., Chestnut Ridge, NY
- Distribution
- nationwide
- Initiated
- April 30, 2019 · Voluntary: Firm initiated
- Classified
- May 22, 2019
- Reported
- May 15, 2019
- Ended
- June 20, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mycophenolate mofetil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.